A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns for affordable early detection.

A team of researchers from UCLA has created a new blood test that may change how doctors detect cancer and other diseases.

Abnormalities in DNA methylation, a genetic modification, may affect disease risk in idiopathic pulmonary fibrosis, according ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, ...

Researchers have developed ThermoCas9, a CRISPR enzyme that can distinguish cancer cells from healthy ones by reading DNA methylation patterns. In lab tests, it selectively edited breast cancer cell ...

Scientists have developed ThermoCas9, a CRISPR enzyme that can distinguish cancer DNA from healthy DNA by reading methylation patterns, potentially reducing off-target edits. In lab tests, it ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.